Celgene (NASDAQ:CELG) - Page 2

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, AVEO, Baker Hughes, Celgene, DowDuPont, Facebook, GE, Goldman Sachs, US Steel and More

Stocks were indicated slightly lower on Friday, but investors also should consider that the Dow Jones industrials are now more than 2,000 points higher than the lows seen at the ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, January 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

January 3, 2019: The S&P 500 closed down 2.5% at 2,447.96. The DJIA closed down 2.8% at 22,686.36. Separately, the Nasdaq closed down 3.0% at 6,463.50. Thursday was a down ...
Read Full Story »

Bristol-Myers, Celgene to Tie a $74 Billion Knot

There's nothing like spending $74 billion on an acquisition to get shareholders' attention. That's what Bristol-Myers Squibb Co. (NYSE: BMY) found out Thursday morning following the announcement of a definitive ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, December 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Applied Materials, Biogen, CyberArk, Electronic Arts, Marathon, Nike, NXP Semiconductors and More

The futures traded higher Friday morning as the fallout from the Federal Reserve raising rates yet again lingered over the market. With all the major indexes having the worst quarter ...
Read Full Story »

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Their Bets in Major Biotechs

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, September 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, September 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »